Bruce Ovbiagele

Northern California Institute/res/edu

16 Sept 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II StudyR01NS1291332022–202716 Sept 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01CiLostAzol for pReventIon of recurrent sTroke in Africa (CLARITY-Africa)R01NS1393462024–202910 Sept 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II StudyR01NS1291332022–20274 Sept 2026reporter.nih.gov

National Institute of Neurological Disorders and Stroke

R01CiLostAzol for pReventIon of recurrent sTroke in Africa (CLARITY-Africa)R01NS1393462024–202927 Aug 2026reporter.nih.gov